Literature DB >> 20515844

MicroRNA in human cancer and chronic inflammatory diseases.

Jagat R Kanwar1, Ganesh Mahidhara, Rupinder K Kanwar.   

Abstract

MicroRNAs (miRNAs) are the non-coding RNAs that act as post-translational regulators to their complimentary messenger RNAs (mRNA). Due to their specific gene silencing property, miRNAs have been implicated in a number of cellular and developmental processes. Also, it has been proposed that a particular set of miRNA spectrum is expressed only in a particular type of tissue. Many interesting findings related to the differential expression of miRNAs in various human diseases including several types of cancers, neurodegenerative diseases and metabolic diseases have been reported. Deregulation of miRNA expression in different types of human diseases and the roles various miRNAs play as tumour suppressors as well as oncogenes, suggest their contribution to cancer and/or in other disease development. These findings have possible implications in the development of diagnostics and/or therapeutics in human malignancies. In this review, we discuss various miRNAs that are differentially expressed in human chronic inflammatory diseases, neurodegenerative diseases, cancer and the further prospective development of miRNA based diagnostics and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515844     DOI: 10.2741/s121

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  16 in total

Review 1.  MicroRNAs: the fine-tuners of Toll-like receptor signalling.

Authors:  Luke A O'Neill; Frederick J Sheedy; Claire E McCoy
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

2.  RB in breast cancer: differential effects in estrogen receptor-positive and estrogen receptor-negative disease.

Authors:  Elizabeth A Musgrove; Robert L Sutherland
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

3.  miR-532-5p promotes breast cancer proliferation and migration by targeting RERG.

Authors:  Lei Huang; Xiaoqiao Tang; Xianbiao Shi; Lei Su
Journal:  Exp Ther Med       Date:  2019-11-12       Impact factor: 2.447

4.  UVA and UVB irradiation differentially regulate microRNA expression in human primary keratinocytes.

Authors:  Anne Kraemer; I-Peng Chen; Stefan Henning; Alexandra Faust; Beate Volkmer; Michael J Atkinson; Simone Moertl; Ruediger Greinert
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?

Authors:  Barbara Seliger; Simon Jasinski; Sven P Dressler; Francesco M Marincola; Christian V Recktenwald; Ena Wang; Rudolf Lichtenfels
Journal:  J Proteome Res       Date:  2011-01-07       Impact factor: 4.466

Review 6.  Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system.

Authors:  Shalmali Bivalkar-Mehla; Janaki Vakharia; Rajeev Mehla; Measho Abreha; Jagat Rakesh Kanwar; Akshay Tikoo; Ashok Chauhan
Journal:  Virus Res       Date:  2010-10-14       Impact factor: 3.303

Review 7.  MicroRNAs in the brain: it's regulatory role in neuroinflammation.

Authors:  Menaka C Thounaojam; Deepak K Kaushik; Anirban Basu
Journal:  Mol Neurobiol       Date:  2013-01-12       Impact factor: 5.590

8.  Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy.

Authors:  Kazunari Hirota; Hiroshi Keino; Makoto Inoue; Hitoshi Ishida; Akito Hirakata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-27       Impact factor: 3.117

Review 9.  Profiling of regulatory microRNA transcriptomes in various biological processes: a review.

Authors:  A A Shah; E Meese; N Blin
Journal:  J Appl Genet       Date:  2010       Impact factor: 2.653

Review 10.  MicroRNAs as novel regulators of neuroinflammation.

Authors:  Dominika Justyna Ksiazek-Winiarek; Magdalena Justyna Kacperska; Andrzej Glabinski
Journal:  Mediators Inflamm       Date:  2013-07-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.